<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
        xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd http://www.google.com/schemas/sitemap-image/1.1 https://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd">
    <url>
      <loc>https://finlandindustrystandard.com/article/914008119-mixpanel-announces-mixpanel-headless-extending-ai-first-product-intelligence-to-ai-agents-and-builders</loc>
      <news:news>
        <news:publication>
          <news:name>Finland Industry Standard</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T09:00:00+00:00</news:publication_date>
        <news:title>Mixpanel Announces Mixpanel Headless, Extending AI-First Product Intelligence to AI Agents and Builders</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24863172-mixpanel-logo-1596x378.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://finlandindustrystandard.com/article/914016427-orion-pharma-to-present-its-first-clinical-data-from-phase-1-2-teades-trial-of-tead-inhibitor-odm-212-at-the-2026-asco-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Finland Industry Standard</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T07:30:00+00:00</news:publication_date>
        <news:title>Orion Pharma to present its first clinical data from Phase 1/2 TEADES trial of TEAD inhibitor ODM-212 at the 2026 ASCO® Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/9e6a027a-eb6c-4e34-993e-b8295e6d598d/small/orionpharma-rgb-press-releases-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://finlandindustrystandard.com/article/914016430-orion-pharma-julkistaa-ensimm-isi-kliinisi-tuloksia-faasi-1-2-teades-tutkimuksesta-odm-212-molekyylill-tead-est-j-2026-asco-vuosikokouksessa</loc>
      <news:news>
        <news:publication>
          <news:name>Finland Industry Standard</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T07:30:00+00:00</news:publication_date>
        <news:title>Orion Pharma julkistaa ensimmäisiä kliinisiä tuloksia Faasi 1/2 TEADES-tutkimuksesta ODM-212-molekyylillä (TEAD-estäjä) 2026 ASCO®-vuosikokouksessa</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/9e6a027a-eb6c-4e34-993e-b8295e6d598d/small/</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://finlandindustrystandard.com/article/914016322-nokia-launches-ai-networking-lab-to-drive-co-innovation-with-partners-and-accelerate-next-era-of-ai-native-data-center-networking</loc>
      <news:news>
        <news:publication>
          <news:name>Finland Industry Standard</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-21T07:00:00+00:00</news:publication_date>
        <news:title>Nokia launches AI networking lab to drive co-innovation with partners and accelerate next era of AI-native data center networking</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/e6523d78-c43a-4057-8aa9-68206d3af4a8/small/nokialogo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://finlandindustrystandard.com/article/913858592-changes-in-nokia-corporation-s-own-shares</loc>
      <news:news>
        <news:publication>
          <news:name>Finland Industry Standard</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-20T14:00:00+00:00</news:publication_date>
        <news:title>Changes in Nokia Corporation&#39;s own shares</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/e6523d78-c43a-4057-8aa9-68206d3af4a8/small/nokialogo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://finlandindustrystandard.com/article/913858602-muutokset-nokia-oyj-n-omien-osakkeiden-omistuksessa</loc>
      <news:news>
        <news:publication>
          <news:name>Finland Industry Standard</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-20T14:00:00+00:00</news:publication_date>
        <news:title>Muutokset Nokia Oyj:n omien osakkeiden omistuksessa</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/e6523d78-c43a-4057-8aa9-68206d3af4a8/small/nokialogo-png.png</image:loc>
        </image:image>
    </url>
</urlset>
